- Home
- PDD vs BSX Comparison
PDD vs BSX Comparison
Compare PDD & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDD | BSX |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.0B | 137.8B |
| IPO Year | 2018 | 1992 |
Fundamental Metrics
Financial Performance| Metric | PDD | BSX |
|---|---|---|
| Price | $100.28 | $74.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 20 |
| Target Price | ★ $137.55 | $109.30 |
| AVG Volume (30 Days) | 8.5M | ★ 20.7M |
| Earning Date | 03-19-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | ★ 9.68 | 1.94 |
| Revenue | ★ $58,790,822,784.00 | $20,074,000,000.00 |
| Revenue This Year | $11.36 | $12.53 |
| Revenue Next Year | $14.74 | $10.88 |
| P/E Ratio | ★ $10.36 | $38.52 |
| Revenue Growth | 12.48 | ★ 19.87 |
| 52 Week Low | $87.11 | $72.69 |
| 52 Week High | $139.41 | $109.50 |
Technical Indicators
Market Signals| Indicator | PDD | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 33.05 | 30.81 |
| Support Level | $101.14 | $72.69 |
| Resistance Level | $106.38 | $79.17 |
| Average True Range (ATR) | 2.48 | 2.52 |
| MACD | 0.07 | -1.26 |
| Stochastic Oscillator | 14.84 | 16.10 |
Price Performance
Historical ComparisonAbout PDD PDD Holdings Inc.
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.